×
About 1,157 results

ALLMedicine™ Oropharyngeal Cancer Center

Research & Reviews  571 results

The impact of HPV vaccination on the prevalence of oropharyngeal cancer (OPC) in a hosp...
https://doi.org/10.1111/jop.13091
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology; Katz J

Aug 3rd, 2020 - Human papillomavirus (HPV) vaccines have been used for the prevention of cervical cancers and their clinical efficacy has not been well established in the prevention of oropharyngeal cancer (OPC), in spite of the common viral etiology. Therefore, ...

The natural history of weight and swallowing outcomes in oropharyngeal cancer patients ...
https://doi.org/10.1007/s00520-020-05628-1
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer; Jovanovic N, Dreyer C et. al.

Aug 2nd, 2020 - Patients treated for oropharyngeal cancer (OPC) are at increased risk for functional decline due to cancer-related impairments and treatment toxicities, often leading to recommendations for enteral nutritional support. This study investigated the ...

Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389683
BMC Cancer; Bußmann L, Laban S et. al.

Jul 30th, 2020 - For loco-regionally advanced, but transorally resectable oropharyngeal cancer (OPSCC), the current standard of care includes surgical resection and risk-adapted adjuvant (chemo) radiotherapy, or definite chemoradiation with or without salvage surg...

Profiling HPV-16-specific T cell responses reveals broad antigen reactivities in oropha...
https://doi.org/10.1084/jem.20200389
The Journal of Experimental Medicine; Bhatt KH, Neller MA et. al.

Jul 27th, 2020 - Cellular immunotherapeutics targeting the human papillomavirus (HPV)-16 E6 and E7 proteins have achieved limited success in HPV-positive oropharyngeal cancer (OPC). Here we have conducted proteome-wide profiling of HPV-16-specific T cell responses...

A novel surgeon credentialing and quality assurance process using transoral surgery for...
https://doi.org/10.1016/j.oraloncology.2020.104797
Oral Oncology; Ferris RL, Flamand Y et. al.

Jul 17th, 2020 - Understanding the role of transoral surgery in oropharyngeal cancer (OPC) requires prospective, randomized multi-institutional data. Meticulous evaluation of surgeon expertise and surgical quality assurance (QA) will be critical to the validity of...

see more →

Clinicaltrials.gov  581 results

The impact of HPV vaccination on the prevalence of oropharyngeal cancer (OPC) in a hosp...
https://doi.org/10.1111/jop.13091
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology; Katz J

Aug 3rd, 2020 - Human papillomavirus (HPV) vaccines have been used for the prevention of cervical cancers and their clinical efficacy has not been well established in the prevention of oropharyngeal cancer (OPC), in spite of the common viral etiology. Therefore, ...

The natural history of weight and swallowing outcomes in oropharyngeal cancer patients ...
https://doi.org/10.1007/s00520-020-05628-1
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer; Jovanovic N, Dreyer C et. al.

Aug 2nd, 2020 - Patients treated for oropharyngeal cancer (OPC) are at increased risk for functional decline due to cancer-related impairments and treatment toxicities, often leading to recommendations for enteral nutritional support. This study investigated the ...

Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389683
BMC Cancer; Bußmann L, Laban S et. al.

Jul 30th, 2020 - For loco-regionally advanced, but transorally resectable oropharyngeal cancer (OPSCC), the current standard of care includes surgical resection and risk-adapted adjuvant (chemo) radiotherapy, or definite chemoradiation with or without salvage surg...

Profiling HPV-16-specific T cell responses reveals broad antigen reactivities in oropha...
https://doi.org/10.1084/jem.20200389
The Journal of Experimental Medicine; Bhatt KH, Neller MA et. al.

Jul 27th, 2020 - Cellular immunotherapeutics targeting the human papillomavirus (HPV)-16 E6 and E7 proteins have achieved limited success in HPV-positive oropharyngeal cancer (OPC). Here we have conducted proteome-wide profiling of HPV-16-specific T cell responses...

A novel surgeon credentialing and quality assurance process using transoral surgery for...
https://doi.org/10.1016/j.oraloncology.2020.104797
Oral Oncology; Ferris RL, Flamand Y et. al.

Jul 17th, 2020 - Understanding the role of transoral surgery in oropharyngeal cancer (OPC) requires prospective, randomized multi-institutional data. Meticulous evaluation of surgeon expertise and surgical quality assurance (QA) will be critical to the validity of...

see more →

News  4 results

ASCO: Deintensified treatment in p16+ oropharyngeal cancer needs evaluation
https://www.mdedge.com/hematology-oncology/article/200108/head-neck-cancers/asco-deintensified-treatment-p16-oropharyngeal?channel=39313
Caleb Rans

May 2nd, 2019 - Treatment deintensification for patients with p16+ oropharyngeal cancer (OPC) should occur only in the context of a clinical trial, according to a provisional clinical opinion released by the American Society of Clinical Oncology (ASCO). “The hypo.

HPV16 Vaccine Yields Added Benefit in Recurrent Throat Cancer
https://www.medpagetoday.com/hematologyoncology/othercancers/75474

Oct 3rd, 2018 - NEW YORK CITY -- Adding a tumor-specific vaccine to PD-1 checkpoint inhibition was safe and effective in HPV16-positive patients with recurrent or metastatic oropharyngeal cancer, a small phase II trial found. Among 24 patients treated with nivolu...

Oral Sex, Smoking Increase Men's HPV Risk
https://www.medpagetoday.com/infectiousdisease/stds/68723

Oct 23rd, 2017 - Action Points Men who smoked and had five or more lifetime oral sex partners had the highest prevalence of oral oncogenic human papilloma virus (HPV) infection (14.9%). The study suggests that even though the prevalence of infection is higher in m...

Novel Approach Reduces Treatment Toxicities in Patients With HPV-Related Oropharyngeal Cancer
https://www.onclive.com/publications/oncology-live/2017/vol-19-no-19/novel-approach-reduces-treatment-toxicities-in-patients-with-hpvrelated-oropharyngeal-cancer

Oct 4th, 2017 - Paul Dent, PhD   Surgeon Chief of Head and Neck Service Andrew S. Poklepovic, MD   Radiation Oncologist Vice Chair, Department of Radiation Oncology, Experimental Therapeutics The incidence of mouth and throat cancer is on the rise due to transmis...

see more →

Patient Education  1 results see all →